To request a free sample copy of this report, please complete the form below.

Our Clients

  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt
  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt
  • FAQs

    Farnesene Market size was valued at USD 50.33 Billion in 2024 and is poised to grow from USD 52.65 Billion in 2025 to USD 75.45 Billion by 2033, growing at a CAGR of 4.6% during the forecast period (2026–2033).

    The global farnesene market is characterized by a competitive landscape with several players vying for market share. The market is witnessing the entry of new players as well as the presence of established companies, fostering intense competition. The key players in the farnesene market are engaged in strategic initiatives such as collaborations, partnerships, mergers, and acquisitions to strengthen their market position and expand their product portfolios. These companies are investing in research and development activities to improve the production processes and enhance the quality of farnesene. Additionally, players are focusing on sustainable and eco-friendly practices, aligning their business strategies with the growing demand for bio-based alternatives. The competitive landscape of the farnesene market is expected to witness further developments as companies strive to innovate and differentiate their products to cater to diverse industry requirements and gain a competitive edge. 'Braskem S.A. ', 'Chevron Phillips Chemical Company ', 'LyondellBasell Industries Holdings B.V. ', 'Eni S.p.A. ', 'Repsol S.A. ', 'SIBUR Holding PJSC ', 'Qatar Energy ', 'BASF SE ', 'Exxon Mobil Corporation ', 'SABIC  ', 'Amyris Inc. ', 'Precigen Inc. ', 'Tate and Lyle Plc ', 'Santa Cruz Biotechnology Inc. ', 'ADL Biopharma ', 'Toronto Research Chemicals Inc. ', 'Triveni chemicals ', 'Antai Fine Chemical ', 'Glentham Life Sciences ', 'U.S. Biological Life Sciences'

    Supportive regulations and policies aimed at promoting the use of bio-based products and reducing carbon emissions are driving the demand for farnesene. Government initiatives, incentives, and mandates encourage the adoption of renewable resources, creating a favorable market environment for farnesene.

    Diversification of End-use Industries: Farnesene is finding applications in a wide range of industries beyond its traditional uses in flavors, fragrances, and polymers. It is being explored in sectors such as cosmetics, lubricants, and specialty chemicals. This diversification of end-use industries is expanding the market potential for farnesene and creating new growth opportunities.

    North America is the dominating region in the global farnesene market. The North America region has a well-established industry with prominent key players in the farnesene sector. The United States has witnessed significant growth in the market due to the presence of major manufacturers and increasing investments in biological products. Various industries related to flavors, fragrances, polymers and cosmetics are driving the market in North America.

    Feedback From Our Clients

    Global Farnesene Market

    Report ID: SQMIG15A2272

    $5,300
    BUY NOW